Metagenomi, Inc. Common Stock (MGX) — Capital Reinvestment Ratio
Metagenomi, Inc. Common Stock (MGX) has a Capital Reinvestment Ratio of 0.05x as of December 2022, meaning it reinvests 0% of its operating cash flow ($67.73 Million) in capital expenditures ($3.51 Million). See debt-free asset ratio of Metagenomi, Inc. Common Stock to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Metagenomi, Inc. Common Stock Capital Reinvestment Ratio (2021–2022)
This chart tracks Metagenomi, Inc. Common Stock's Capital Reinvestment Ratio across 2 annual periods. Check cash flow reinvestment rate of Metagenomi, Inc. Common Stock to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Metagenomi, Inc. Common Stock (2021–2022)
Year-by-year Capital Reinvestment Ratio for Metagenomi, Inc. Common Stock from 2021 to 2022. For live market cap and broader valuation context, see MGX market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.47x | $29.72 Million | $13.98 Million | ▲ +292.9% |
| 2021 | 0.12x | $24.26 Million | $2.90 Million | — |